Opened the debate
Proposes a national programme to screen for type 1 diabetes in children to improve early diagnosis, reduce DKA rates, and provide families with better preparation. Emphasises the importance of identifying individuals at risk before symptoms appear to allow access to disease-modifying drugs like Teplizumab that can delay onset by two to three years. Advocates for clear criteria based on the Wilson and Jungner principles, focusing on the early stages from ages 2-4, 6-8, and 10-15, aiming for a screening rate of around 80%.